VERONA PHARMA PLC - ADR (VRNA)
US9250501064 - ADR
Full estimates are only available for subscribed users, you can see which data is available below.
Subscribed users also see more surprise data, now it is restricted to 4 quarters.
Examples of complete estimate data are available for MSFT and AAPL.
Registered users have access to more data. Please register or login for additional estimates and surprises .
| 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue YoY % growth | 40M | 460K -98.85% | -100.00% | 21.341M | 158.79M 644.06% | 312.56M 96.84% | 516.26M 65.17% | 778.27M 50.75% | 1.157B 48.66% | 1.512B 30.68% | 1.87B 23.68% | ||
| EBITDA YoY % growth | -73.66M -41.95% | -72.68M 1.33% | -75.11M -3.34% | N/A 10.94% | -78.948M -18.02% | -108.426M -37.34% | -47.022M 56.63% | N/A | N/A | N/A | N/A | N/A | |
| EBIT YoY % growth | -74.28M -41.76% | -73.31M 1.31% | -75.75M -3.33% | -70.098M 10.80% | -161.343M -138.78% | -74.334M 53.93% | 23.415M 131.50% | 203.26M 768.08% | 432.75M 112.90% | 704.86M 62.88% | 988.69M 40.27% | 1.406B 42.21% | |
| Operating Margin | N/A | -183.28% | -16,467.39% | N/A | -756.02% | -46.81% | 7.49% | 39.37% | 55.60% | 60.92% | 65.39% | 75.19% | |
| EPS YoY % growth | -2.47 19.86% | -0.97 60.73% | -1.11 -14.43% | -0.78 38.74% | -2.20 -224.00% | -0.41 81.25% | -0.23 44.44% | 1.16 603.69% | 2.21 91.04% | 2.87 30.02% | 3.52 22.56% | 4.12 17.10% |
All data in USD
| Q4 / 24 | Q1 / 25 | Q2 / 25 | Q3 / 25 | Q4 / 25 | |
|---|---|---|---|---|---|
| EPS Q2Q % growth | -0.45 -151.22% | -0.04 87.25% | -0.04 95.36% | -0.03 94.54% | -0.04 90.98% |
| Revenue Q2Q % growth | 17.014M | 27.032M | 38.629M | 49.645M 782.73% | 56.8M 233.84% |
| EBITDA Q2Q % growth | N/A | N/A | N/A | N/A | N/A |
| EBIT Q2Q % growth | -34.168M -78.94% | -28.607M -5.18% | -26.086M 61.88% | -21.308M 47.60% | -17.705M 48.18% |
All data in USD
| Period | Reported | Estimate | Difference | Surprise |
|---|---|---|---|---|
| Q3 2024 Q2Q % growth | -0.56 -211.11% | -0.51 | -0.05 | -9.80% |
| Q2 2024 Q2Q % growth | -0.88 -1,000.00% | -0.30 | -0.58 | -192.46% |
| Q1 2024 Q2Q % growth | -0.32 -33.33% | -0.17 | -0.15 | -91.30% |
| Q4 2023 Q2Q % growth | -0.18 -12.50% | -0.27 | 0.09 | 32.13% |
| Q3 2023 Q2Q % growth | -0.18 21.74% | -0.29 | 0.11 | 36.97% |
| Q2 2023 Q2Q % growth | -0.08 75.00% | -0.30 | 0.22 | 73.19% |
| Q1 2023 Q2Q % growth | -0.24 40.00% | -0.19 | -0.05 | -23.84% |
| Q4 2022 Q2Q % growth | -0.16 60.00% | -0.10 | -0.06 | -53.04% |
| Q3 2022 Q2Q % growth | -0.23 -243.75% | -0.17 | -0.06 | -37.49% |
| Q2 2022 Q2Q % growth | -0.32 13.51% | -0.39 | 0.07 | 16.89% |
| Q1 2022 Q2Q % growth | -0.40 -11.11% | -0.45 | 0.05 | 10.87% |
| Q4 2021 Q2Q % growth | -0.40 | -0.49 | 0.09 | 19.14% |
| Q3 2021 Q2Q % growth | 0.16 134.78% | -0.37 | 0.53 | 143.57% |
| Q2 2021 Q2Q % growth | -0.37 43.94% | -0.45 | 0.08 | 17.18% |
| Q1 2021 Q2Q % growth | -0.36 62.11% | -0.48 | 0.12 | 25.51% |
| Q4 2020 Q2Q % growth | -0.40 45.21% | -0.36 | -0.04 | -12.04% |
| Q3 2020 Q2Q % growth | -0.46 51.37% | -0.22 | -0.24 | -108.14% |
| Q2 2020 Q2Q % growth | -0.66 24.14% | -0.48 | -0.18 | -36.70% |
| Q1 2020 Q2Q % growth | -0.95 -77.24% | -0.67 | -0.28 | -42.56% |
| Q4 2019 Q2Q % growth | -0.73 -151.72% | -1.12 | 0.39 | 34.64% |
| Q3 2019 Q2Q % growth | -0.95 -3,162.07% | -0.81 | -0.14 | -16.66% |
| Q2 2019 Q2Q % growth | -0.87 -1,480.95% | -0.77 | -0.10 | -13.35% |
| Q1 2019 Q2Q % growth | -0.54 66.79% | -0.50 | -0.03 | -6.52% |
| Q4 2018 Q2Q % growth | -0.29 | -0.52 | 0.23 | 44.50% |
| Q3 2018 Q2Q % growth | -0.03 | -0.55 | 0.52 | 94.69% |
| Q2 2018 Q2Q % growth | 0.06 | -0.99 | 1.05 | 106.37% |
| Q1 2018 Q2Q % growth | -1.61 | -0.73 | -0.89 | -121.83% |
| Period | Reported | Estimate | Difference | Surprise |
|---|---|---|---|---|
| Q3 2024 Q2Q % growth | 5.624M | 2.055M | 3.569M | 173.67% |
| Q4 2023 Q2Q % growth | -100.00% | % | ||
| Q4 2022 Q2Q % growth | 460K | 3.643M | -3.183M | -87.37% |
| Q3 2022 Q2Q % growth | -100.00% | 3.643M | -3.643M | -100.00% |
| Q3 2021 Q2Q % growth | 40M | 4.25M | 35.75M | 841.18% |
| Next Q (1 month) | Next Q (3 month) | Next Year (1 month) | Next Year (3 month) | |
|---|---|---|---|---|
| EPS | -27.58% | -58.33% | -27.62% | 10.62% |
| Revenue | 0% | -15.89% | 0% | 204.31% |